Jason Menzo

Jason Menzo is the Chief Operating Officer for Foundation Fighting Blindness, the world’s largest private funder of research for treatments and cures of blinding retinal degenerative diseases. The Foundation has raised nearly $800 million since its inception and is currently funding more than 90 research projects globally. Fighting Blindness has also launched the RD Fund with over $70 million under management to fuel startup companies in the retinal degeneration space. Prior to joining the Foundation, Jason was a co-founder and Business Unit Head of Sun Ophthalmics. As one of four founding members, he led the commercial team build-out launching the business into the well-known entity it is today. He was also a founding member of the US business for Nicox SA, where he led the commercial launches of several ophthalmic brands and helped successfully exit by acquisition (Valeant Pharmaceuticals, 2014). He has previously held positions of increasing responsibility with Bausch + Lomb, Inspire Pharmaceuticals, and Bayer Healthcare.